Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway
Cited by 21
Related Papers
Neuropeptide Substance P Improves Osteoblastic and Angiogenic Differentiation Capacity of Bone Marrow Stem Cells<i>In Vitro</i>
|BioMed Research International|2014|56
Repression of YAP by NCTD disrupts NSCLC progression
|Oncotarget|2016|52